Gyre Therapeutics Inc (GYRE) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Gyre Therapeutics Inc   (NASDAQ: GYRE)

Gyre Therapeutics Inc

Officers & Directors


Gordon Carmichael, Ph.D.
Director

Rodney L. Nussbaum
Director

Renate Parry, Ph.D.
Director

Nassim Usman, Ph.D.
Director

Thomas Eastling
Director

Songjiang Ma
President and Director

Han Ying, Ph.D.
Chief Executive Officer and Director (Principal Executive Officer)

Ruoyu Chen
Chief Financial Officer (Principal Financial and Accounting Officer)

Ying Luo, Ph.D.
Chairman of the Board of Directors

Grant Thornton Zhitong Certified Public Accountants LLP
Auditor,

Gyre Therapeutics Inc currently has 618 employees.






GYRE Management Effectiveness GYRE Revenue per Employee GYRE Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.